Healthtech Startups
16,920 companies tagged Healthtech, with their investors and founders.
Inupathy makes a wearable collar for dogs that monitors heart rate and activity through sensors, providing pet owners with insights into their dog's physical and emotional state via a mobile app and home station.
2 investors
Invenra develops proprietary platform technologies to discover and develop novel bi- and multi-specific antibody therapies, with an initial focus on oncology. The company is advancing pipelines of antibody candidates with partners and intends to expand into additional disease categories.
2 investors
Invidyo is an AI-powered video and radar monitoring system for baby monitoring and senior care, offering real-time alerts for events like falls, crying, sleep patterns, and calls for help. It serves parents and caregivers with a smart baby camera, while Invidyo Health provides privacy-focused monitoring using radar sensors and cameras for senior care facilities.
2 investors
Align Technology develops dental technology for orthodontic treatment, including clear aligners and intraoral scanners used to straighten teeth. It uses 3D printing, aligner materials, and software algorithms to plan digital tooth movement for patients and orthodontic professionals.
2 investors
Inwords is an AI-powered application that provides self-guided talk therapy and journaling for individuals seeking mental health support. The platform combines conversational AI with cognitive behavioral therapy principles to help users process emotions and build self-awareness.
2 investors
Iodine Software's page presents Waystar, an AI-powered platform that automates healthcare revenue cycle management, including insurance verification, prior authorizations, price transparency, and payments. It serves hospitals, health systems, and other healthcare providers to improve financial performance and reduce claim denials.
2 investors
iOmx Therapeutics is a biotech company developing novel cancer therapies. Based in Munich's Martinsried biotech hub, the company focuses on transforming cancer treatment through scientific research and collaborative innovation.
2 investors
A clinical-stage biotech company developing novel targeted cancer therapies and immunomodulatory drugs with a global equity strategy. The company operates a translational medicine platform and focuses on solid tumors and drug-resistant cancers.
2 investors
iosBio develops oral, thermostable vaccine candidates using its ESD platform, with a lead program (OraPro-EBV) targeting Epstein-Barr Virus. The company operates in the biotechnology and vaccine development sector.
2 investors
iQuartic provides an AI-driven platform that uses OCR, NLP, and machine learning to convert structured and unstructured medical records into machine-readable data and extract meaningful clinical information. Its tools support medical coding, risk adjustment, and analytics for healthcare organizations to identify coding and care gaps and predict patient-specific events.
2 investors
IQVIA is a healthcare data and technology company that supports life sciences organizations in research, clinical development, and commercialization of medicines and medical solutions.
2 investors
IrazΓΊ Oncology develops cancer immunotherapies using a proprietary Outer Membrane Vesicles (OMV) platform based on engineered bacterial nanoparticles that deliver cancer antigens. The biotech company, founded in 2022, is building a pipeline of immunotherapies for cancer patients.
2 investors
iRhythm provides wearable cardiac monitoring devices and AI-powered analysis services for clinicians to diagnose heart arrhythmias. The platform combines engineered ECG monitors, machine learning algorithms, and expert clinical review to deliver actionable diagnostic reports.
2 investors
Iridex makes laser systems, EndoProbe handpieces, and vitreoretinal surgical consumables used for precision eye surgery in hospitals and ambulatory surgery centers. Its products serve ophthalmic surgeons in operating-room settings.
2 investors
Iris Medicine is an early-stage biotech developing RNA therapies based on its small binding RNA (sbRNA) platform, which uses cooperative RNAi binding to selectively silence mutant genes carrying expanded pathologic repeat sequences while preserving healthy alleles. Its lead programs target repeat expansion disorders including Huntington's Disease, C9orf72 ALS, and the Spinocerebellar Ataxias.
2 investors
Ischemia Care operates a CLIA-certified laboratory that develops blood tests for stroke patients using RNA expression analysis to determine stroke cause and improve clinical outcomes. The company serves hospitals and emergency care settings in the United States, focusing on reducing cryptogenic strokes and enabling guideline-directed patient care.
2 investors
Isla is a health-tech company offering a digital pathway platform (DPP) that automates routine clinical admin and connects care workflows for NHS clinical teams. Founded in 2019 and based in London, it serves over 40 NHS Trusts with tools for media-led diagnostics and automated care pathways.
2 investors
K Health provides an agentic clinical AI platform for health systems, offering symptom investigation, patient triage, and automated documentation integrated into Epic and MyChart. It supports fully integrated primary care through consumer intake tools, provider-facing workflow support, and a 24/7 virtual clinic staffed by credentialed providers, serving U.S. health systems.
2 investors
issin develops everyday health care products and services designed to naturally support family wellness without conscious effort. The company builds solutions that integrate health management seamlessly into daily life.
2 investors
IVIDATA Life Sciences is a French consulting firm serving healthcare and life sciences players, supporting projects from clinical research through market launch. Its roughly 140 consultants work across three areas: biometrics and data, clinical operations and development, and regulatory affairs and vigilance, with a European focus.
2 investors
Jade Biosciences develops therapeutic antibodies targeting autoimmune diseases, with a lead candidate in clinical development for immunoglobulin A nephropathy, a chronic kidney disease. The company's pipeline includes additional candidates designed to modulate immune system responses in autoimmune conditions.
2 investors
Jaide Health provides AI-powered real-time interpretation and translation services for healthcare organizations to communicate with limited English proficiency (LEP) patients across clinical and administrative interactions. The platform uses HIPAA-compliant AI to reduce costs and improve access to care.
2 investors
Jasper Therapeutics develops briquilimab, a targeted anti-KIT monoclonal antibody designed to deplete mast cells for treating chronic immunological and inflammatory diseases. The company is running clinical studies in chronic spontaneous urticaria, chronic inducible urticaria, and allergic asthma.
2 investors
A platform that connects clients with interpreters, offering competitive per-minute pricing and flexible workflow integration across devices.
2 investors